질병 통제 및 예방 백신 시장 : 제품 유형별, 유형별, 투여 경로별, 연령층별, 적응증별, 지역별

Disease Control And Prevention Vaccine Market is estimated to be valued at USD 114.9 Bn in 2026 and is expected to reach USD 255.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.4% from 2026 to 2033.

Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

Market Dynamics

The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.

Key features of the study

• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global disease control and prevention vaccine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
• Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
• The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.

Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Live-attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
• By Type (Revenue, USD Bn, 2021-2033)
  • Monovalent Vaccines
  • Multivalent Vaccines
• By Route of Administration (Revenue, USD Bn, 2021-2033)
  • Oral
  • Injectable
• By Age Group (Revenue, USD Bn, 2021-2033)
  • Pediatric Vaccines
  • Adult Vaccines
• By Indication (Revenue, USD Bn, 2021-2033)
  • Infectious Diseases
  • Cancer
  • Other Indications
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Johnson & Johnson
  • Moderna, Inc.
  • BioNTech SE
  • Novavax, Inc.
  • Sinovac Biotech Ltd.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech International Ltd.
  • CSL Limited
  • Dynavax Technologies Corporation
  • Valneva SE Inovio Pharmaceuticals, Inc.
  • Vaxart, Inc.
  • Astellas Pharma Inc.
  • Daiichi Sankyo Company
  • Limited and Panacea Biotec Ltd.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By Indication
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Governmental Initiative
• Product Pipeline
• Regulatory Landscape
• PEST Analysis
• PORTER'S Five Forces

4. Global Disease Control and Prevention Vaccines Market, By Product Type, 2021-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Live-attenuated Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Inactivated Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Recombinant Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Toxoid Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global Disease Control and Prevention Vaccines Market, By Type, 2021-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Monovalent Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Multivalent Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2021-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global Disease Control and Prevention Vaccines Market, By Age Group, 2021-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Pediatric Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Adult Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

8. Global Disease Control and Prevention Vaccines Market, By Indication, 2021-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Other Indications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

9. Global Disease Control and Prevention Vaccines Market, By Regions, 2021-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, By Region, 2022-2033
  • Regional Trends
• North America
  • U.S.
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Canada
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
• Europe
  • U.K.
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Germany
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Italy
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • France
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Spain
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Russia
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Rest of Europe
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
• Asia Pacific
  • China
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Japan
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • India
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • ASEAN
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Australia
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • South Korea
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Rest of Asia Pacific
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
• Latin America
  • Brazil
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Mexico
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Rest of Latin America
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
• Africa
  • North Africa
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Central Africa
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • South Africa
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
• Middle East
  • GCC Countries
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Israel
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
  • Rest of Middle East
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
    • Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)

10. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Sanofi Pasteur
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • AstraZeneca PLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Moderna, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • BioNTech SE
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Novavax, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Sinovac Biotech Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Bharat Biotech International Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • CSL Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Dynavax Technologies Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Valneva SE Inovio Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Astellas Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Daiichi Sankyo Company, Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Panacea Biotec Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Analyst Views

11. Section

• References
• Research Methodology
• About Us and Sales Contact